During the follow-up, no local or systemic adverse events were observed and the patient was satisfied with the therapy after two months with an increasing trend by passing time.
← all excerpts
The Healing Effect of Bone Marrow-Derived Stem Cells in Knee Osteoarthritis: A Case Report.
2
—
—
The sentences
in patients with knee OA treated with intra-articular injection of 40×10 autologous bone marrow-derived stem cells (BM-SCs) observed that the patients demonstrated rapid and progressive improvement of algofunctional indices by 1 year and also showed a highly significant decrease of poor cartilage areas with improvement of cartilage quality. 13 Injection of BM-SCs in knee OA was shown to improve pain, functional status of the knee, and walking distance without any adverse events.